12
REGIONAL STAGING OF PROSTATE CANCER ON PELVIC MRI Juliana B Starcevich, MD Steven C Eberhardt, MD University of New Mexico

Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

REGIONAL STAGING OF PROSTATE CANCER ON PELVIC

MRI

Juliana B Starcevich, MD

Steven C Eberhardt, MD

University of New Mexico

Page 2: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

CLINICAL IMPLICATIONS

• High risk patients (>5% chance of for lymph node metastases) undergo nodal staging. The most reliable method is lymph node dissection. However, it is invasive and positive lymph nodes can be found outside the routine and extended lymph node dissection templates. 1

• Pre-operative MRI may be employed for cancer detection and biopsy guidance as well as local staging. During these exams, images covering the greater pelvis allow potential detection of suspect lymph nodes, both within and beyond the usual surgical template for nodal dissection.

Page 3: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

REGIONAL: N1

• Pelvic

• Obturator

• Internal iliac (hypogastric)

• External iliac

• Sacral

• Aortic

• Common iliac

• Inguinal

• Supraclavicular

• Cervical

• Scalene

• Retroperitoneal NOS

DISTANT: M1a

REGIONAL VS DISTANT LYMPH NODES

Page 4: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

External Iliac and Internal Iliac (hypogastric) Lymph Nodes

Obturator Lymph Nodes

REGIONAL LYMPH NODES (N1)

Page 5: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

Common Iliac Lymph Nodes Superficial and Deep Inguinal Lymph Nodes

DISTANT LYMPH NODES (M1a)

It is useful for prostate MRI protocols to contain one sequence including the aortic bifurcation through inguinal lymph nodes as their involvement is considered metastatic disease, rather than regional nodal disease.3

Page 6: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

ABNORMAL LYMPH NODES: SIZE

• The literature to support what nodal size means for metastatic risk varies.

• Sensitivity and specificity rests with threshold one sets for suspicion of metastatic nodal involvement.

• A size threshold of 1.5 cm is almost universally specific for metastatic involvement. 4

• The traditional threshold is 1cm short axis for oval lymph nodes and 8 mm diameter for round lymph nodes. 5

ABNORMAL LYMPH NODES: SIZE

Page 7: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

ABNORMAL LYMPH NODES: SHAPE

• In contrast to the typical oval shape of a normal lymph node, suspicious morphologies include the following:6

• Round

• Irregular

• Indistinct border

ABNORMAL LYMPH NODES: MORPHOLOGY

Page 8: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

• Lymph nodes are suspicious if brighter than groin lymph nodes on high b value images (with corresponding low ADC signal intensity).6

• Restricted diffusion and abnormal morphology are particularly helpful in determining if a normal sized lymph node is suspicious for metastatic involvement.

ABNORMAL LYMPH NODES: DWI

Page 9: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

• 64 year old man with PSA of 19.8 ng/ml, no biopsy.

• Despite measuring 5mm short axis, the left internal iliac lymph node is suspicious due to:

• Irregular shape

• High signal intensity on the b 1000 series with low signal intensity on the ADC map

• Involvement of this left internal iliac lymph node constitutes N1 disease

b 1000 ACD

T1

Page 10: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

• 64 year old man with PSA of 19.8 ng/ml, no biopsy.

• Right superficial inguinal lymph node is suspicious because of:

• Large size of 13 mm short axis

• High signal intensity on the b 1000 series with low signal intensity on the ADC map

• Involvement of an inguinal lymph node constitutes M1a disease.

b 1000 ACD

T1

Page 11: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

• 72 year old man with PSA of 4.9 ng/ml and Gleason 4+3 prostate cancer on biopsy.

• Common iliac lymph node is suspicious due to:

• Larger size, 9 mm short axis

• This lymph node was completely visible on a larger FOV Post-contrast T1 sequence, incompletely imaged on the Pre-contrast T1.

• A suspicious common iliac lymph node constitutes M1a disease.

• This case highlights the importance of imaging to the level of the aortic bifurcation.

Post-contrast T1 with fat saturation

Pre-Contrast T1 Image #1

Page 12: Regional Staging of Prostate cancer with mri · patients with prostate cancer: a meta-analysis." Clinical radiology63.4 (2008): 387-395. 5. Jager, GerritJ., et al. "Pelvic adenopathy

REFERENCES

1. Hövels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, HoogeveenYL, Severens JL, Barentsz JO. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63:387–395.

2. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol. 2004;172:1840–1844.

3. Weinreb, Jeffrey C., et al. "PI-RADS prostate imaging–reporting and data system: 2015, version 2." European urology 69.1 (2016): 16-40.

4. Hövels, AM1, et al. "The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis." Clinical radiology 63.4 (2008): 387-395.

5. Jager, Gerrit J., et al. "Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence." AJR. American journal of roentgenology 167.6 (1996): 1503-1507.

6. Thoeny, Harriet C., et al. "Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging." Radiology 273.1 (2014): 125-135.

REFERENCES